BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2014

May 6, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2014-05-02

Reporting Person: Erck Stanley C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-02	Automatic Stock Option Grant	$8.47	A	15000	Acquired	2024-05-02	Common Stock (15000)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan.

F2: Vests 1/12 per month over twelve months beginning June 2, 2014.